Navigation Links
Onyx Pharmaceuticals Presents Carfilzomib Data at 53rd American Society of Hematology Annual Meeting
Date:12/12/2011

SOUTH SAN FRANCISCO, Calif., Dec. 12, 2011 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced final results from a Phase 2 study, known as the 004 study, evaluating single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and/or refractory multiple myeloma. Results on prolonged infusion of carfilzomib and speed of response were also announced. These data were presented at the 53rd American Society of Hematology (ASH) Annual Meeting in San Diego, CA.

Abstract #813: Final Results from the Bortezomib-Naive Group of PX-171-004, a Phase 2 Study of Single-Agent Carfilzomib in Patients with Relapsed and/or Refractory Multiple Myeloma
Results from the 004 Phase 2 study evaluated single-agent carfilzomib in patients with relapsed and/or refractory multiple myeloma who had received one to three prior treatments and had not been previously treated with bortezomib. In 67 evaluable patients, carfilzomib achieved an overall response rate (ORR) of 52 percent and a clinical benefit rate (CBR) of 64 percent when administered at 27mg/m(2). Sixty-four percent of patients were refractory to their most recent therapy prior to entering the trial. Overall response is defined as a partial response or greater.[i]  The median time-to-progression (TTP), duration of response (DOR) and overall survival (OS) were not reached in this study, designed to provide patients with up to 12 cycles of carfilzomib.  Forty-two percent of patients completed greater than 10 cycles and 22 patients continued treatment beyond one year in the extension protocol PX-171-010.

"This Phase 2 study demonstrates promising single-agent activity of carfilzomib in patients with relapsed and/or refractory multiple myeloma who have not been previously treated with bortezomib," said Ravi Vij, M.D., Associate Professor, Department of Medicine,
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 2015 Research and Markets ( ... "Asia-Pacific Internal Trauma Fixation Devices Market by ... To 2019" report to their offering. ... is estimated to grow at a CAGR of ... technological advancement, rising incidences of road accidents, increasing ...
(Date:5/6/2015)... GenSpera, Inc. (OTCQB: GNSZ) announced today that the patent ... process in 17 countries and regions, including Europe ... China , Brazil and ... patent application will extend the exclusivity period for GenSpera,s core ... drug candidate, mipsagargin, until 2033. This recent patent ...
(Date:5/6/2015)... Ohio , May 6, 2015 Cardinal ... a 13 percent increase in the company,s quarterly dividend ... quarterly dividend is payable on July 15, 2015 to shareholders of ...    About Cardinal Health Headquartered in ... (NYSE: CAH ) is a $91 billion ...
Breaking Medicine Technology:Asia-Pacific Internal Trauma Fixation Devices (Internal Trauma Fixation Plates, Screws, Rod Wires & Pins, Fusion Nails) Market 2015 2GenSpera Enters National Phase with Patent Application for Injectable Prodrug Formulations 2Cardinal Health Raises Quarterly Dividend 2
... Food and Drug Administration has scheduled the third in ... academics, biotechnology companies, and those unfamiliar with the process ... (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) (Logo:   ... with the Drug Information Association, will focus on the ...
... Oct. 13 Highland Capital Management, L.P. ("Highland"), ... billion of assets under management, announced today that ... --  which previously traded as (OTC Bulletin Board: ... transaction and filed documents with the SEC to ...
Cached Medicine Technology:FDA Schedules Third Orphan Drug Workshop for Nov. 4-5, 2010 2Highland Capital Management Announces 100% Ownership of American HomePatient, Completes Successful Public to Private Transition For Leading Provider of Home Respiratory Therapy 2Highland Capital Management Announces 100% Ownership of American HomePatient, Completes Successful Public to Private Transition For Leading Provider of Home Respiratory Therapy 3
(Date:5/6/2015)... Prime Pacific Health Innovations, the ... announce a new series of universal, one-time-use speculum ... footprint while improving treatment efficacy and saving therapists ... the world’s first waste hose designed specifically for ... claims the company’s president, Mr. Delmar Vogel. , ...
(Date:5/6/2015)... May 06, 2015 “ SideChef ” was featured ... look at the latest and coolest applications on the market for ... technology expert, conducted the app review and shared with viewers how ... the day when to be a good navigator people had to ... and now everyone is a master navigator. Well what if people ...
(Date:5/6/2015)... 2015 vcfo, a specialized consulting firm ... operational support to optimize business performance and productivity, announced ... and Michael Scheaffer. Both Lynch and Scheaffer have more ... , “We are delighted to add Jack and ... “Leveraging their background in financial management and leadership, Mike ...
(Date:5/6/2015)... 2015 Healthcare jobs platform, ... launching in mid-February. The company connects hospitals, home-health, and ... experience in the industry. Likewise, job seekers are able ... Kyle Johnson, CTO, unique traffic to the site is ... "Each new job posting brings targeted, interested candidates to ...
(Date:5/6/2015)... 06, 2015 The Alliance for ... regenerative medicine and advanced therapies community, today announced ... offering an in-depth look at sector trends and ... , The report is available online here ... data points, available here . , Using ...
Breaking Medicine News(10 mins):Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3Health News:An Application to Guide Users through Recipes Was Featured on NewsWatch Television 2Health News:vcfo Adds Two Senior Executives to Growing Team 2Health News:Job Seekers Turn to JobMedic to Find Healthcare Positions - JobMedic.com Reaches 1,000 User Milestone 2Health News:The Alliance for Regenerative Medicine Releases Quarterly Data Report, Highlighting Key Sector Trends and Metrics in Q1 2015 2Health News:The Alliance for Regenerative Medicine Releases Quarterly Data Report, Highlighting Key Sector Trends and Metrics in Q1 2015 3
... aiding certain patients with the blood cancer , , WEDNESDAY, ... of the once-banned drug thalidomide for patients with myeloma ... as it is to science: Don,t judge results too ... therapy regimens increased the odds of a complete remission, ...
... Counseling for All Combat Veterans, WASHINGTON, July 9 ... in 39 additional,communities across the country where the Department ... 2009., "Community-based Vet Centers -- already in all ... health program," said Dr. James B. Peake,Secretary of Veterans ...
... conditions cause significant decrease in body,s ability to repair ... News) -- Diabetes and being over- or underweight can ... the conclusion of two reports to be presented July ... of Human Reproduction & Embryology, in Barcelona, Spain. , ...
... Inc.,(NYSE and SWX: ZMH) announced today its second quarter ... over the Internet on,Thursday, July 24, 2008, at 8:00 ... will be made available at 7:00 a.m. the,morning of ... be accessed via Zimmer,s Investor Relations,website at http://investor.zimmer.com ...
... the elderly and people without health insurance especially vulnerable, ... Every summer, an estimated 6,200 Americans are hospitalized for ... who were hospitalized died, according to the latest ... Healthcare Research and Quality. , Severe heat exposure, ...
... neighborhoods to advance benefits of selecting Michigan ... July 9 The Associated Food &,Petroleum Dealers (AFPD) ... to make fresh, local produce more readily,available to Metro ... program called "Buy Local, Eat Fresh.", "We have ...
Cached Medicine News:Health News:Thalidomide Continues to Show Benefits Against Myeloma 2Health News:Thalidomide Continues to Show Benefits Against Myeloma 3Health News:VA Vet Centers Coming to 39 Communities 2Health News:Diabetes, Weight Tied to Male Infertility 2Health News:Heat Exposure a Dangerous Summer Threat 2Health News:Select Michigan and Associated Food & Petroleum Dealers Launch 'Buy Local, Eat Fresh' 2Health News:Select Michigan and Associated Food & Petroleum Dealers Launch 'Buy Local, Eat Fresh' 3
... AUDICOR is the first, easy-to-use, non-invasive ... quickly rule-in cardiac dysfunction including acute ... other high-risk cardiac conditions. Designed to ... AUDICOR products enable clinicians caring for ...
... 5702 is a heavy-duty, stainless steel, 1,000 ... special needs of bariatric patients. An extra-large, ... ease and security. The scale automatically returns ... you to weigh a continuous stream of ...
... Parathyroid hormone (PTH) is synthesized by ... in response to decreased extracellular calcium ... bone resorption and decreasing calcium excretion ... the circulation, intact PTH is rapidly ...
... of insulin is the C-terminal cleavage product ... to the mature insulin molecule. Although the ... does undergo significant liver or extra-renal metabolism ... half-life than insulin [1]. In addition, C-peptide ...
Medicine Products: